WO2007091276A3 - Novel crystal form of omeprazol sodium - Google Patents
Novel crystal form of omeprazol sodium Download PDFInfo
- Publication number
- WO2007091276A3 WO2007091276A3 PCT/IN2007/000048 IN2007000048W WO2007091276A3 WO 2007091276 A3 WO2007091276 A3 WO 2007091276A3 IN 2007000048 W IN2007000048 W IN 2007000048W WO 2007091276 A3 WO2007091276 A3 WO 2007091276A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- crystal form
- novel crystal
- omeprazol
- sodium
- omeprazol sodium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The present invention refers to a novel crystal form of omeprazol sodium as well as a process for making the same. Said compound is freeze-dried and can be processed to pharmaceutical dosage form by using mannitol as excipient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN367/DEL/2006 | 2006-02-10 | ||
IN367DE2006 | 2006-02-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007091276A2 WO2007091276A2 (en) | 2007-08-16 |
WO2007091276A3 true WO2007091276A3 (en) | 2007-12-06 |
Family
ID=38345552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2007/000048 WO2007091276A2 (en) | 2006-02-10 | 2007-02-07 | Novel crystal form of omeprazol sodium |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007091276A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105147616A (en) * | 2015-09-11 | 2015-12-16 | 青岛蓝盛洋医药生物科技有限责任公司 | Medicine namely pantoprazole sodium composition dry suspension for treating gastric ulcer |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2528993A1 (en) | 2003-06-10 | 2004-12-23 | Teva Pharmaceutical Industries Ltd. | Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
CN101250182B (en) * | 2008-03-26 | 2010-09-01 | 江苏奥赛康药业有限公司 | Lansoprazole sodium |
SI22806A (en) * | 2008-06-23 | 2009-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | New crystalline forms of sodium rabeprazole |
US8071781B2 (en) | 2008-11-11 | 2011-12-06 | Syn-Tech Chem. & Pharm. Co., Ltd. | Process for preparing rabeprazole sodium |
RU2449784C1 (en) * | 2010-12-23 | 2012-05-10 | Государственное образовательное учреждение высшего профессионального образования "Воронежский государственный университет" (ГОУ ВПО ВГУ) | Method for prevention of gastric mucosal damage caused by administration of nonsteroid anti-inflammatory agents |
RU2449787C1 (en) * | 2011-01-12 | 2012-05-10 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" | Method of treating erosions and ulcers of gastric mucosa |
CN104887673B (en) * | 2011-06-07 | 2017-12-29 | 成都国为生物医药有限公司 | A kind of pharmaceutical composition containing Esomeprazole sodium and preparation method thereof |
CN102552178B (en) * | 2012-01-13 | 2013-01-09 | 山东罗欣药业股份有限公司 | Lyophilized powder injection of rabeprazole sodium medicinal composition and preparation method of lyophilized powder injection |
CN103772355B (en) * | 2012-10-25 | 2016-03-02 | 天津汉瑞药业有限公司 | Sodium rabeprazole compound |
CN103709140A (en) * | 2013-10-11 | 2014-04-09 | 寿光富康制药有限公司 | Pantoprazole sodium crystal and preparation method thereof |
CN103709141A (en) * | 2013-10-14 | 2014-04-09 | 寿光富康制药有限公司 | Crystal forms and amorphous forms of rabeprazole sodium |
CN104072482A (en) * | 2014-06-17 | 2014-10-01 | 江苏奥赛康药业股份有限公司 | Rabeprazole sodium compound and pharmaceutical composition thereof |
CN107773529B (en) * | 2016-08-24 | 2020-06-16 | 华仁药业股份有限公司 | Esomeprazole sodium and sodium chloride injection and preparation method thereof |
CN106957302A (en) * | 2017-04-12 | 2017-07-18 | 山东裕欣药业有限公司 | A kind of method of RABEPRAZOLE SODIUM prepared by super-critical anti-solvent technology |
CN109456306A (en) * | 2018-10-26 | 2019-03-12 | 山西普德药业有限公司 | A kind of esomeprazole sodium and the lyophilized preparation it includes it |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994002141A1 (en) * | 1992-07-28 | 1994-02-03 | Astra Aktiebolag | Injection and injection kit containing omeprazole and its analogs |
-
2007
- 2007-02-07 WO PCT/IN2007/000048 patent/WO2007091276A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994002141A1 (en) * | 1992-07-28 | 1994-02-03 | Astra Aktiebolag | Injection and injection kit containing omeprazole and its analogs |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105147616A (en) * | 2015-09-11 | 2015-12-16 | 青岛蓝盛洋医药生物科技有限责任公司 | Medicine namely pantoprazole sodium composition dry suspension for treating gastric ulcer |
Also Published As
Publication number | Publication date |
---|---|
WO2007091276A2 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007091276A3 (en) | Novel crystal form of omeprazol sodium | |
WO2010030359A3 (en) | Macrocyclic hepatitis c serine protease inhibitors | |
WO2010108074A3 (en) | Inhibitors of pi3 kinase | |
GEP20135786B (en) | Pyrrole compounds | |
WO2007130824A3 (en) | Fused heterocylic compounds and their use as mglur5 modulators | |
WO2010146179A3 (en) | Solid pharmaceutical composition comprising rivaroxaban | |
WO2010129057A3 (en) | Tetracycline compounds | |
MY174002A (en) | Combination theraphy for the treatment of diabetes | |
WO2010089768A3 (en) | Bortezumib containing pharmaceutical composition | |
WO2011159903A3 (en) | Asenapine maleate | |
WO2008098985A3 (en) | Pharmaceutical composition for the treatment of il-8 mediated diseases | |
WO2011025982A3 (en) | Tetracycline compounds | |
WO2011023367A3 (en) | Bisphosphonate-prodrugs | |
WO2008035380A3 (en) | An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts | |
WO2011123536A8 (en) | Polycyclic tetracycline compounds | |
WO2007130821A3 (en) | Mglur5 modulators ii | |
WO2005079759A3 (en) | Pharmaceutical composition for oral application and method for preparing thereof | |
WO2010132670A3 (en) | Pentacycline compounds | |
WO2009074247A8 (en) | Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament | |
WO2008098978A3 (en) | Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor | |
WO2010012459A3 (en) | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms | |
EA201300647A1 (en) | OPTIMIZED SYNTHESIS OF PURE NONPOLYMORPHIC CRYSTALLINE YELLOW ACIDS WITH A PARTICLE SIZE | |
WO2012030106A3 (en) | Production method of intermediate compound for synthesizing medicament | |
WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
IL200950A0 (en) | Process for the production of a buprenorphine pharmaceutical composition for administration to mouth mucosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07706194 Country of ref document: EP Kind code of ref document: A2 |